These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 8988962)

  • 21. [Carbohydrate-deficient transferrin. A new, highly specific marker for chronic alcohol consumption].
    Seitz G; Stickel F; Fiehn W; Werle E; Simanowski UA; Seitz HK
    Dtsch Med Wochenschr; 1995 Mar; 120(12):391-5. PubMed ID: 7705200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse.
    Sarkola T; Eriksson CJ; Niemelä O; Sillanaukee P; Halmesmäki E
    Acta Obstet Gynecol Scand; 2000 May; 79(5):359-66. PubMed ID: 10830762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma-glutamyltransferase.
    Sillanaukee P; Olsson U
    Clin Chem; 2001 Apr; 47(4):681-5. PubMed ID: 11274018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced clinical utility of gamma-CDT in a general population.
    Sillanaukee P; Massot N; Jousilahti P; Vartiainen E; Poikolainen K; Olsson U; Alho H
    Alcohol Clin Exp Res; 2000 Aug; 24(8):1202-6. PubMed ID: 10968658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.
    Bråthen G; Bjerve KS; Brodtkorb E; Helde G; Bovim G
    Alcohol Clin Exp Res; 2001 Jan; 25(1):46-53. PubMed ID: 11198714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV).
    Reynaud M; Schellenberg F; Loisequx-Meunier MN; Schwan R; Maradeix B; Planche F; Gillet C
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1414-9. PubMed ID: 11003208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences.
    Anton RF; Moak DH
    Alcohol Clin Exp Res; 1994 Jun; 18(3):747-54. PubMed ID: 7943686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbohydrate deficient transferrin in detecting relapse in alcohol dependence.
    Mitchell C; Simpson D; Chick J
    Drug Alcohol Depend; 1997 Nov; 48(2):97-103. PubMed ID: 9363408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological markers of alcohol consumption and effect of calcitonin in nonalcoholic men: a prospective, double-blind study.
    Elomaa VV; Löyttyniemi E; Kãrkkäinen P; Salaspuro M; Laitinen K
    Alcohol Clin Exp Res; 1996 Aug; 20(5):830-5. PubMed ID: 8865956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative sensitivity of carbohydrate-deficient transferrin and gamma-glutamyltransferase.
    Rosalki SB
    Alcohol Alcohol; 1996 May; 31(3):305-6. PubMed ID: 8844037
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics.
    Anton RF; Stout RL; Roberts JS; Allen JP
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1456-62. PubMed ID: 9802528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbohydrate-deficient transferrin: an aid to early recognition of alcohol relapse.
    Allen JP; Litten RZ; Fertig JB; Sillanaukee P
    Am J Addict; 2001; 10(s1):s24-s28. PubMed ID: 11268818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here?
    Anton RF
    Alcohol; 2001 Nov; 25(3):185-8. PubMed ID: 11839464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of contemporary biomarkers in the detection of chronic alcohol use.
    Montalto NJ; Bean P
    Med Sci Monit; 2003 Dec; 9(12):RA285-90. PubMed ID: 14646983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption.
    Litten RZ; Allen JP; Fertig JB
    Alcohol Clin Exp Res; 1995 Dec; 19(6):1541-6. PubMed ID: 8749824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
    Baros AM; Wright TM; Latham PK; Miller PM; Anton RF
    Alcohol Alcohol; 2008; 43(2):192-7. PubMed ID: 18039674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?
    Bertholet N; Winter MR; Cheng DM; Samet JH; Saitz R
    Alcohol Alcohol; 2014; 49(4):423-9. PubMed ID: 24740846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP).
    Alte D; Luedemann J; Rose HJ; John U
    Alcohol Clin Exp Res; 2004 Jun; 28(6):931-40. PubMed ID: 15201636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of alcohol dependence: experiences of using biological markers in monitoring and prevention of relapse.
    Borg S
    Alcohol Alcohol; 1996 Nov; 31(6):621-4. PubMed ID: 9010556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations of CDT and GGT in detecting relapses in patients attending an alcohol problems clinic.
    Limin S; Jarvie DR; Chick J; Simpson D
    Scott Med J; 1999 Oct; 44(5):140-2. PubMed ID: 10629909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.